Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,000 | 45,000 | 44,000 | 56,000 | 64,000 |
| Marketable Securities | 6,000 | 5,000 | 0 | 23,000 | 14,000 |
| Receivables | 361,000 | 395,000 | 417,000 | 423,000 | 445,000 |
| Inventories | 354,000 | 327,000 | 334,000 | 355,000 | 376,000 |
| Income taxes - deferred | 152,000 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 163,000 | 164,000 | 158,000 | 156,000 |
| TOTAL | $992,000 | $935,000 | $959,000 | $1,015,000 | $1,055,000 |
| Non-Current Assets | |||||
| PPE Net | 567,000 | 939,000 | 938,000 | 945,000 | 940,000 |
| Investments And Advances | 99,000 | 79,000 | 90,000 | 0 | 55,000 |
| Intangibles | 1,671,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 98,000 | 1,830,000 | 1,848,000 | 1,906,000 | 1,858,000 |
| TOTAL | $2,435,000 | $2,848,000 | $2,876,000 | $2,851,000 | $2,853,000 |
| Total Assets | $3,427,000 | $3,413,000 | $3,483,000 | $3,514,000 | $3,572,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,000 | 65,000 | 361,000 | 343,000 | 92,000 |
| Accrued Expenses | 352,000 | 315,000 | 0 | 0 | 318,000 |
| Other current liabilities | 3,000 | 5,000 | 5,000 | 12,000 | 3,000 |
| TOTAL | $819,000 | $803,000 | $932,000 | $1,044,000 | $1,055,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 574,000 | 566,000 | 567,000 | 570,000 | 678,000 |
| Other Non-Current Liabilities | 99,000 | 110,000 | 116,000 | 120,000 | 115,000 |
| TOTAL | $673,000 | $676,000 | $683,000 | $690,000 | $793,000 |
| Total Liabilities | $1,492,000 | $1,479,000 | $1,615,000 | $1,734,000 | $1,848,000 |
| Shareholders' Equity | |||||
| Common Shares | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| Retained earnings | 1,116,000 | 1,058,000 | 976,000 | 858,000 | 752,000 |
| Other shareholders' equity | -113,000 | -141,000 | -142,000 | -144,000 | -116,000 |
| TOTAL | $1,935,000 | $1,934,000 | $1,868,000 | $1,780,000 | $1,724,000 |
| Total Liabilities And Equity | $3,427,000 | $3,413,000 | $3,483,000 | $3,514,000 | $3,572,000 |